SMAD2 and melanoma: For SMAD2 to act as suppressor for PAX3 it requires SKI (Xu et al., 2000, Yang et al., 2008), and we detected SMAD2 in SKI immunoprecipitates from melanoma cells under steady-state conditions (Figure 4C).